JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹11 Cr | ₹6.09 Cr | ₹7.96 Cr | ₹8.08 Cr | ₹6.06 Cr |
What is the latest Contingent Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹6.09 Cr |
Mar2022 | ₹7.96 Cr |
Mar2021 | ₹8.08 Cr |
Mar2020 | ₹6.06 Cr |
How is Contingent Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 84.29 | |
Mar2023 | ₹6.09 Cr | -23.57 | |
Mar2022 | ₹7.96 Cr | -1.44 | |
Mar2021 | ₹8.08 Cr | 33.42 | |
Mar2020 | ₹6.06 Cr | - |
Compare Contingent Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,574.7 Cr | 2.6% | 0.5% | 75% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 2.6% |
0.5% |
75% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses